260 related articles for article (PubMed ID: 10745938)
1. [Specific cyclo-oxygenase inhibitors. 2. Gastric toxicity?].
Blondon H
Presse Med; 2000 Mar; 29(9):482-3. PubMed ID: 10745938
[No Abstract] [Full Text] [Related]
2. [Side effects cause enormous costs. Expensive arthritis therapy].
MMW Fortschr Med; 2001 Nov; 143(46):60. PubMed ID: 11759607
[No Abstract] [Full Text] [Related]
3. COX-2 inhibitors. Magic bullets or merely mortal?
Harv Health Lett; 2000 Feb; 25(4):4. PubMed ID: 10637015
[No Abstract] [Full Text] [Related]
4. Nonsteroidal anti-inflammatory drugs for perioperative pain control.
Burgess FW; Browning RA
Med Health R I; 2001 Oct; 84(10):327-8. PubMed ID: 11693050
[No Abstract] [Full Text] [Related]
5. Selective COX-2 inhibitors.
Pasero C; McCaffery M
Am J Nurs; 2001 Apr; 101(4):55-6. PubMed ID: 11301685
[No Abstract] [Full Text] [Related]
6. Arthritis. Should you be taking a COX-2 inhibitor?
Harv Health Lett; 2001 Nov; 27(1):1-3. PubMed ID: 11724695
[No Abstract] [Full Text] [Related]
7. [Gastrointestinal complications caused by NSAIDs. Over 60% of arthrosis patients are endangered].
MMW Fortschr Med; 2003 Mar; 145(10):60. PubMed ID: 12688036
[No Abstract] [Full Text] [Related]
8. [Selective Cox-2 inhibitor in osteoarthritis and rheumatoid arthritis. No increased risk for the heart].
MMW Fortschr Med; 2003 Mar; 145(11):60. PubMed ID: 12688204
[No Abstract] [Full Text] [Related]
9. Selective COX-2 inhibition.
Silas S; Clegg DO
Bull Rheum Dis; 1999; 48(2):1-4. PubMed ID: 12024416
[No Abstract] [Full Text] [Related]
10. [Clinical pharmacology of the selective COX-2 inhibitors].
Burian M; Geisslinger G
Orthopade; 2003 Dec; 32(12):1078-87. PubMed ID: 14655004
[TBL] [Abstract][Full Text] [Related]
11. [Analgesic in osteoporosis. Why so conservative with dosage?].
Pfeifer M
MMW Fortschr Med; 2002 Sep; 144(35-36):9. PubMed ID: 12380349
[No Abstract] [Full Text] [Related]
12. Summaries for patients. The cost-effectiveness of cyclooxygenase-2 inhibitors for treating chronic arthritis.
Ann Intern Med; 2003 May; 138(10):I39. PubMed ID: 12755582
[No Abstract] [Full Text] [Related]
13. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373027
[No Abstract] [Full Text] [Related]
14. [New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results].
Oliw E; Wollheim FA
Lakartidningen; 2000 Jun; 97(24):2942-4. PubMed ID: 10900877
[No Abstract] [Full Text] [Related]
15. [Gastrointestinal damage induced by celecoxib and rofecoxib in rats].
Laudanno OM; Cesolari JA; Esnarriaga J; Rista L; Piombo G; Maglione C; Aramberry LJ; Sambrano JS; Godoy A; Rocaspana A
Acta Gastroenterol Latinoam; 2000; 30(1):27-33. PubMed ID: 10855352
[TBL] [Abstract][Full Text] [Related]
16. Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?
Jüni P; Rutjes AW; Dieppe PA
BMJ; 2002 Jun; 324(7349):1287-8. PubMed ID: 12039807
[No Abstract] [Full Text] [Related]
17. [Safety of specific cyclo-oxygenase 2 inhibitors].
Lems WF; van de Laar MA; Bijlsma JW
Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1044-7. PubMed ID: 11414163
[TBL] [Abstract][Full Text] [Related]
18. Are rofecoxib and celecoxib safer NSAIDS?
Drug Ther Bull; 2000 Nov; 38(11):81-6. PubMed ID: 11138599
[TBL] [Abstract][Full Text] [Related]
19. [Celebrex: confirmed effectiveness and safety (new data)].
Nasonov EL
Ter Arkh; 2001; 73(5):57-61. PubMed ID: 11517753
[No Abstract] [Full Text] [Related]
20. What's all the fuss? Safety concerns about COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex).
Wooltorton E
CMAJ; 2002 Jun; 166(13):1692-3. PubMed ID: 12126328
[No Abstract] [Full Text] [Related]
[Next] [New Search]